They are especially relevant right now, because the FDA issued 30 warning letters to compounded GLP-1 telehealth companies in early 2026, and on April 30, 2026 proposed a rule that would - if finalized - permanently close the large-scale compounding pathway for semaglutide and tirzepatide
HSA and FSA accounts qualify for PlexusDx medications, providing additional tax-advantaged savings for eligible patients
The standard melanotan-1 dosage protocol for research use involves subcutaneous injection of 0.251.0mg daily, administered 3060 minutes before controlled UV exposure, with reconstituted peptide stored at 28C and used within 28 days
Ahead, the best apps for GLP-1 users, based on how people are actually using them
Although partial weight regain was observed after withdrawal, overall long-term efficacy remained clear